Europe Female Sexual Dysfunction Market and Competitive Landscape Highlights 2016 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Europe
Female Sexual Dysfunction Market and Competitive Landscape Highlights –
2016″ drug pipelines to their offering.

Europe Female Sexual Dysfunction Market and Competitive Landscape
Highlights – 2016, provides comprehensive insights into Female Sexual
Dysfunction pipeline products, Female Sexual Dysfunction epidemiology,
Female Sexual Dysfunction market valuations and forecast, Female Sexual
Dysfunction products sales and competitive landscape.

This report is classified into nine sections – Female Sexual Dysfunction
overview including etiology, pathophysiology, and diagnosis, Female
Sexual Dysfunction treatment options, Female Sexual Dysfunction pipeline
products, Female Sexual Dysfunction market analysis in Europe and by
each country.

The market analysis comprises of Female Sexual Dysfunction epidemiology,
key products marketed for Female Sexual Dysfunction, market valuations
and forecast, products sales and market shares.

Research Scope:

– Pipeline: Find out the products in clinical trials for the treatment
of Female Sexual Dysfunction by development phase 3, phase 2, and phase
1, by pharmacological class and companies developing the products

– Epidemiology: Find out the number of patients diagnosed (prevalence)
with Female Sexual Dysfunction

– Products: Identify key products marketed and prescribed for Female
Sexual Dysfunction including trade name, molecule name, and company

– Product Sales: Find out the sales revenues of Female Sexual
Dysfunction products, both branded and generics

– Market Valuations: Find out the market size for Female Sexual
Dysfunction products in 2015 for the markets: Find out how the market
advanced from 2010 and forecast to 2020

– Products Market Share: Find out the market shares for key Female
Sexual Dysfunction products

Key Topics Covered:

1 Disease Overview

2 Female Sexual Dysfunction Treatments

3 Female Sexual Dysfunction Pipeline

4 Europe Female Sexual Dysfunction Market Insights

5 Germany Female Sexual Dysfunction Market Insights

6 France Female Sexual Dysfunction Market Insights

7 Italy Female Sexual Dysfunction Market Insights

8 Spain Female Sexual Dysfunction Market Insights

9 UK Female Sexual Dysfunction Market Insights

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/k7z76b/europe_female

Related Topics: Women’s
Health, Sexual
and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716